Shanghai Pharmaceuticals Holding Co Ltd Class A
601607: XSHG (CHN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
¥49.16 | Mypxtt | Bjfxzsdq |
Shanghai Pharmaceuticals Full Year in Line, Fair Value Estimate Unchanged
Narrow-moat Shanghai Pharmaceuticals, or SPH, announced full-year results that were in line with our expectations. Our fair values are unchanged at HKD 20.30 per H-share and 17.00 per A-share. The market is pricing them at a 24% discount for H-shares and 16% premium for A-shares.